» Articles » PMID: 12593960

The Production and Characteristics of Solid Lipid Nanoparticles (SLNs)

Overview
Journal Biomaterials
Date 2003 Feb 21
PMID 12593960
Citations 74
Authors
Affiliations
Soon will be listed here.
Abstract

Modified high shear homogenization and ultrasound techniques were employed to produce solid lipid nanoparticles (SLNs). Model drug mifepristone had been incorporated in SLNs. The mean particle size measured by laser diffractometry (LD) was found to be 106 nm with a narrow particle distribution of polydispersity index, 0.278. Differential scanning calorimetry and X-ray diffraction measurements suggested that the majority of the SLNs were less ordered arrangement of crystals, and this was favorable for increasing the drug loading capacity. The drug entrapment efficiency (EE%) of SLNs was more than 87 percent and showed relatively long-term physical stability as the leakage was very small after being stored for one month. Therefore, seemed this modified method could prepare high quality SLNs loading lipophilic drugs. It is a simple, available and effective method to produce SLNs.

Citing Articles

Formulation and Evaluation of Butenafine Hydrochloride-Incorporated Solid Lipid Nanoparticles as Novel Excipients for the Treatment of Superficial Fungal Infections.

Baviskar A, Kashid V, Ahirrao S, Bhambere D, Akul M Turk J Pharm Sci. 2024; 21(4):313-326.

PMID: 39224083 PMC: 11589089. DOI: 10.4274/tjps.galenos.2023.80799.


Quality by design driven development of lipid nanoparticles for cutaneous targeting: a preliminary approach.

Patel V, Mehta T, Shah J, Soni K Drug Deliv Transl Res. 2024; 15(4):1393-1410.

PMID: 39145818 DOI: 10.1007/s13346-024-01685-9.


Development of a Versatile Nanostructured Lipid Carrier (NLC) Using Design of Experiments (DoE)-Part II: Incorporation and Stability of Butamben with Different Surfactants.

Matarazzo A, Rios C, Geronimo G, Ondei R, de Paula E, Breitkreitz M Pharmaceutics. 2024; 16(7).

PMID: 39065560 PMC: 11280378. DOI: 10.3390/pharmaceutics16070863.


Co-delivery of paclitaxel and curcumin loaded solid lipid nanoparticles for improved targeting of lung cancer: and investigation.

Li M, Fang G, Zahid F, Saleem R, Ishrat G, Ali Z Heliyon. 2024; 10(9):e30290.

PMID: 38720725 PMC: 11076978. DOI: 10.1016/j.heliyon.2024.e30290.


Nanotechnology-based Herbal Drug Formulation in the Treatment of Diabetes Mellitus.

Bhadouria N, Alam A, Kaur A Curr Diabetes Rev. 2024; 21(1):e310124226554.

PMID: 38299420 DOI: 10.2174/0115733998282162240116202813.